Development asset linked to Oncopeptides AB (publ) in public FDA and regional records.
pharma · Multiple Myeloma · Recurrent glioblastoma
Oncopeptides AB (publ)
Oncopeptides AB (publ) drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Stockholm, SE HQ
2000 Founded
85 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Stockholm, SE
- Founded
- 2000
- Employees
- 85
- Programs
- 2
- Drugs
- 2
- Patents
- 0
Oncopeptides AB (publ) pipeline
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Oncopeptides AB (publ) drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
melphalan flufenamide
Antineoplastic and immunomodulating agents (L01)Antineoplastic and immunomodulating agents (L01) compound in Oncopeptides AB (publ)'s portfolio.